News

As growing numbers of people seek out healing with the help of psychedelic medicines, the need for professional integration providers, whether therapists or coaches, has never been higher. Without this support, psychedelic journeys intended for healing purposes can become distant memories, rather than experiences that result in lasting, concrete changes.

Johns Hopkins has been awarded a grant from the National Institutes of Health to explore the potential impacts of psilocybin on tobacco addiction, the first NIH grant awarded in over a half century to directly investigate the therapeutic effects of a classic psychedelic.

Lamar Odom, whose battle with drug addiction led to a near-death experience, is opening up about his use of a synthetic drug that he said helped him beat addiction.Odom, 41, said being treated with small doses of ketamine under medical supervision for the past two years has helped keep him sober."I went to rehab and did some other things, but ketamine came into my life at the right time," Odom told ABC News' Steve Osunsami in an interview that aired Monday on "Good Morning America." "I'm feeling amazing.""I'm alive. I'm sober. I'm happy," he said.